Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology

被引:0
|
作者
Muller-Quernheim, J [1 ]
机构
[1] Hosp Med, Res Ctr Borstel, D-23845 Borstel, Germany
关键词
sarcoidosis; idiopathic pulmonary fibrosis; collagen-vascular diseases; serum markers; alveolitis; immunopathogenesis;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Immunopathogenic mechanisms in sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary manifestations of collagen-vascular diseases maintain an alveolitis which may lead to irreversible organ damage. The classical parameters used in the management of pulmonary involvement of these disorders are chest X-ray and pulmonary function test which do not gauge alveolitis but rather pulmonary impairment. From the immunopathogenesis several serological parameters have been delineated estimating different aspects of inflammatory processes. Cytokines, soluble cytokine receptors, metabolites, enzymes, extracellular matrix components, soluble adhesion molecules, and other serum components have been evaluated to serve as serological markers of alveolitis. The mechanisms gauged by these markers, and their clinical usefulness are discussed in this review.
引用
收藏
页码:22 / 37
页数:16
相关论文
共 50 条
  • [1] INTERSTITIAL LUNG-DISEASE OF UNKNOWN ETIOLOGY
    TURNERWARWICK, M
    CHEST, 1991, 100 (01) : 232 - 233
  • [2] Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D
    Takahashi, H
    Shiratori, M
    Kanai, A
    Chiba, H
    Kuroki, Y
    Abe, S
    RESPIROLOGY, 2006, 11 : S51 - S54
  • [3] CYCLOSPORINE AS A TREATMENT FOR INTERSTITIAL LUNG-DISEASE OF UNKNOWN ETIOLOGY
    MOOLMAN, JA
    BARDIN, PG
    ROSSOUW, DJ
    JOUBERT, JR
    THORAX, 1991, 46 (08) : 592 - 595
  • [4] Fatigue In Patients With Sarcoidosis And Other Interstitial Lung Diseases: A Comparative Study
    Gomez, A. D.
    Collard, H. R.
    King, T. E., Jr.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [5] Staging systems and disease severity assessment in interstitial lung diseases
    Tomassetti, Sara
    Ryu, J. H.
    Poletti, V.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (05) : 463 - 469
  • [6] Interstitial Lung Disease and Sarcoidosis
    Sharp, Michelle
    Mustafa, Ali M.
    Farah, Naima
    Bonham, Catherine A.
    CLINICS IN CHEST MEDICINE, 2023, 44 (03) : 575 - 584
  • [7] RESPIRATORY FUNCTION IN SARCOIDOSIS AND OTHER INTERSTITIAL LUNG DISEASES WITH SIMILAR RADIOLOGICAL APPEARANCE
    VALE, JR
    SCANDINAVIAN JOURNAL OF RESPIRATORY DISEASES, 1971, 52 (01): : 3 - &
  • [8] A RARE ETIOLOGY OF INTERSTITIAL LUNG DISEASE
    Kyaw, Phyo
    Song, Mingchen
    Ullah, Saad
    Nayeemuddin, Faraaz
    Gao, John
    CHEST, 2019, 156 (04) : 892A - 892A
  • [9] Lung function and disease activity in sarcoidosis - Disease activity in sarcoidosis
    Bradvik, I
    Wollmer, P
    Evander, E
    Sloth, M
    Larusdottir, H
    BlomBulow, B
    Jonson, B
    ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY, 1996, 6 (01): : 61 - 70
  • [10] EXPRESSION AND IMMUNE RECOGNITION OF STRESS PROTEINS IN SARCOIDOSIS AND OTHER CHRONIC INTERSTITIAL LUNG-DISEASES
    STATON, JM
    DENCH, JE
    CURRIE, B
    FITZPATRICK, DR
    HIMBECK, RP
    ALLEN, R
    BRUCE, J
    ROBINSON, BWS
    BIELEFELDTOHMANN, H
    IMMUNOLOGY AND CELL BIOLOGY, 1995, 73 (01): : 23 - 32